| REVIEW ARTICLE |
|
| Year : 2015 | Volume
: 28
| Issue : 2 | Page : 282-288 |
|
|
Clinical aspects of the haemostasis-inflammation interface
Ali Z Galal, Sabry A Shoeib, Hany S El Barbary, Wael R Abu-Sabala
Department of Internal medicine, Al-Mahallah al-Kubra Hospital, Menoufia University, Menoufia Governorate, Egypt
Correspondence Address:
Wael R Abu-Sabala
Al-Mahallah al-Kubra, Bolkina 31951
Egypt
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/1110-2098.163865
|
|
|
Objective
The aim of the study was to evaluate the clinical aspects of the haemostasis and inflammation interface.
Data sources
Data sources were medical text books, medical journals and medical websites that have updated research with keywords (haemostasis and inflammation) in the title of the paper.
Study selection
Systematic reviews that addressed haemostasis and inflammation and the role of haemostasis and inflammation in clinical studies were included.
Data extraction
A special search was performed in MEDLINE with keywords (haemostasis and inflammation) in the title of the papers; extraction was performed, including assessment of the quality and validity of the papers that met the prior criteria that describe haemostasis and inflammation and their role in clinical studies.
Data synthesis
It included the main result of the review. Each study was reviewed independently; the obtained data were rebuilt in a new language according to the need of the researcher and arranged in topics through the article.
Conclusion
Improved understanding of the molecular mechanisms that play a role in the bidirectional relationship between inflammation and haemostasis could help in the clinical management of patients by identifying new potential therapeutic targets that can modify excessive and inappropriate activation or deregulation of both systems. On the basis of experimental and clinical studies, it is likely that simultaneous modulation of both inflammatory and haemostatic activities, rather than specific therapy aimed at only one component, could be more successful in the treatment of clinical states and diseases in which a close link between inflammation and haemostasis considerably contributes to the pathogenesis or progression of the disease. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
